Sort
21,281 grants matching “influenza”
Age-Associated B Cells Specialized for Immunity to Pathogens?
$209,375Susan L Swain · Univ Of Massachusetts Med Sch Worcester · R21 · FY2022 · AG
Host response-based screening for unexpected or emerging respiratory viruses
$209,375Ellen Flescher Foxman · Yale University · R21 · FY2021 · AI
Harnessing Age-Associated B cells for a Universal Influenza Vaccine for the Aged
$209,375Susan L Swain · Univ Of Massachusetts Med Sch Worcester · R21 · FY2024 · AI
Interplay between canonical and non-canonical interferons in defense against respiratory viruses
$209,375Ellen Flescher Foxman · Yale University · R21 · FY2025 · AI
Discovery of NR4A1/2 ligands controlling tissue-resident memory T (Trm) cells
$209,375Fabio Rinaldo Santori · Yale University · R21 · FY2018 · AI
Impact of TcR Signal Strength at the Effector Checkpoint on Protective CD4 T Cell Immunity to Influenza Virus
$209,375Susan L Swain · Univ Of Massachusetts Med Sch Worcester · R21 · FY2021 · AI
Modeling human anti-viral humoral responses in the young and elderly
$209,375Robert Thomas Woodland · Univ Of Massachusetts Med Sch Worcester · R21 · FY2016 · AI
Maintaining Robust T Cell Immunity For Broad Protection Against Influenza
$209,375Susan L Swain · Univ Of Massachusetts Med Sch Worcester · R21 · FY2020 · AI
Protective function of virus-induced age-associated B cells
$209,375Susan L Swain · Univ Of Massachusetts Med Sch Worcester · R21 · FY2019 · AI
Suppression of the type I IFN gene signature by the long non-coding RNA-Lucat-1
$209,375Katherine A Fitzgerald · Univ Of Massachusetts Med Sch Worcester · R21 · FY2020 · AI
VACCINE STRATEGIES TO CIRCUMVENT AGE-ASSOCIATED IMMUNE DEFECTS
$209,375Susan L Swain · Univ Of Massachusetts Med Sch Worcester · R21 · FY2019 · AG
Optimization of a computationally designed antiviral for influenza
$209,358Merika Treants Koday · Virvio, Inc. · R41 · FY2016 · AI
Interdisciplinary Training in Virology and Gene Therapy
$209,340Ren Sun · University Of California Los Angeles · T32 · FY2007 · AI
Reversing aging-induced lymphatic dysfunction to improve immune function
$209,320Timothy P Padera · Massachusetts General Hospital · R21 · FY2023 · AG
Delivery of Powdered Vaccines for Improving Newborn Vaccination
$209,229Mei X Wu · Massachusetts General Hospital · R21 · FY2020 · AI
Using the Default Effect to Promote Healthy Behavior
$209,092Gretchen B Chapman · Rutgers, The State Univ Of N.J. · R01 · FY2010 · AG
Pathogenesis, Treatment and Prevention of Emerging Infectious Diseases
$209,030H. Clifford Lane · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Evaluation of HIV-1 Env intracytoplasmic domain as an AIDS vaccine immunogen
$209,014Ronald C Montelaro · University Of Pittsburgh At Pittsburgh · R21 · FY2007 · AI
Impact of chronic infection in the aged on the response to vaccination
$209,008Andrea M Cooper · Trudeau Institute, Inc. · R21 · FY2007 · AG
MECHANISMS OF TCDD PULMONARY IMMUNOTOXICITY
$208,968Washington State University · R01 · FY2001 · ES
Vaccine Induced Activation of T Follicular Helper Cell Subsets
$208,903Hideki Ueno · Baylor Research Institute · U19 · FY2011 · AI
Background Oriented Schlieren (BOS) Visualization for Evaluation of Risk in Aerosol-Generating Procedures
$208,902Bryan Schmidt · Case Western Reserve University · R21 · FY2023 · EB
Genetic susceptibility to severe respiratory disease induced by SARS-CoV2
$208,825Steven R Kleeberger · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES
Leadership Administrative Core - LAC
$208,802Sabra L Klein · Johns Hopkins University · U54 · FY2021 · AG
Leadership Administrative Core - LAC
$208,798Sabra L Klein · Johns Hopkins University · U54 · FY2020 · AG